menu
    • menu

    Company profile for Seelos Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a responsibly-driven company focused on achieving the most efficient development of products that address significant unmet needs in CNS disorders and in rare diseases. Seelos intends to become a leading biopharmaceutical company focused on neurological and psychiatric disorders, including orphan indications. Advancing SLS-002 in suicidality in PTSD and in major depressive disorder. Collaborate with Team Sanfilippo Foun...
    We are a responsibly-driven company focused on achieving the most efficient development of products that address significant unmet needs in CNS disorders and in rare diseases. Seelos intends to become a leading biopharmaceutical company focused on neurological and psychiatric disorders, including orphan indications. Advancing SLS-002 in suicidality in PTSD and in major depressive disorder. Collaborate with Team Sanfilippo Foundation (TSF) to advancing SLS-005 to address the needs of patients with Sanfilippo syndrome.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Seelos TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Park Avenue New York, NY 10022
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://seelostherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    New York biotech files for bankruptcy
    New York biotech files for bankruptcy

    22 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/after-als-trial-misses-mark-seelos-has-filed-bankruptcy

    FIERCE BIOTECH
    22 Nov 2024
    Share Share
    Seelos Therapeutics Announces Delisting From Nasdaq To OTC Market
    Seelos Therapeutics Announces Delisting From Nasdaq To OTC Market

    15 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-notice-of-delisting-from-nasdaq-and-transfer-of-listing-to-over-the-counter-market-302276319.html

    PR NEWSWIRE
    15 Oct 2024
    Share Share
    Seelos Therapeutics Announces 1-for-16 Reverse Stock Split
    Seelos Therapeutics Announces 1-for-16 Reverse Stock Split

    25 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-1-for-16-reverse-stock-split-302257773.html

    PR NEWSWIRE
    25 Sep 2024
    Share Share
    Seelos Prices $1.1M Registered Direct & Private Placement
    Seelos Prices $1.1M Registered Direct & Private Placement

    16 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-pricing-of-1-1-million-registered-direct-offering-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules-302148673.html

    PR NEWSWIRE
    16 May 2024
    Share Share
    Seelos Therapeutics Announces 1-for-8 Reverse Stock Split
    Seelos Therapeutics Announces 1-for-8 Reverse Stock Split

    14 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-1-for-8-reverse-stock-split-302144966.html

    PR NEWSWIRE
    14 May 2024
    Share Share
    Seelos Provides Update on Top-Line Results ALS Study SLS-005 (IV Trehalose)
    Seelos Provides Update on Top-Line Results ALS Study SLS-005 (IV Trehalose)

    19 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/seelos-therapeutics-provides-update-on-top-line-results-from-its-amyotrophic-lateral-sclerosis-als-study-with-sls-005-iv-trehalose-302092918.html

    PR NEWSWIRE
    19 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search